RARX - Ra Pharmaceuticals, Inc.
| Previous Close | 46.83 |
| Open | 46.93 |
| Bid | 46.96 x 1100 |
| Ask | 47.03 x 900 |
| Day's Range | 46.83 - 47.05 |
| 52 Week Range | 14.65 - 47.35 |
| Volume | 398,265 |
| Avg. Volume | 1,144,503 |
| Market Cap | 2.205B |
| Beta (3Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.00 |
| Earnings Date | Aug 7, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.00 |
- Zacks
Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug
Ra Pharmaceuticals (RARX) begins dosing of the first patient in its phase II study of zilucoplan for the treatment of immune-mediated necrotizing myopathy.
- Business Wire
Ra Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of Zilucoplan for IMNM
Ra Pharmaceuticals, Inc. (RARX) today announced the initiation of dosing in its Phase 2 clinical trial of zilucoplan for the treatment of immune-mediated necrotizing myopathy (IMNM). “IMNM is a chronic, severe, and debilitating autoimmune disease, and current treatment options are limited and non-specific,” said Andrew Mammen, M.D., Ph.D., Muscle Disease Unit Leader, Laboratory of Muscle Stem Cells and Gene Regulation, and Principal Investigator for the Phase 2 study at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD. The randomized, double-blind, placebo-controlled, multi-center, Phase 2 clinical trial will evaluate the safety, tolerability, and efficacy of zilucoplan in patients with IMNM who are positive for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) or anti-signal recognition particle (SRP) autoantibodies.
- PR Newswire
Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Trust BancShares (CART), and Highlands Bankshares (HLND) Investors to Contact Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to the following companies' entry into merger agreements:
- ACCESSWIRE
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARX
NEW YORK, NY / ACCESSWIRE / November 26, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Innophos Holdings, Inc. (NASDAQ:IPHS) The investigation ...
- GlobeNewswire
Rigrodsky & Long, P.A. Files Class Action Suit Against Ra Pharmaceuticals, Inc.
WILMINGTON, Del., Nov. 25, 2019 -- Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District.
- GlobeNewswire
Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – RARX, IPHS, CISN, LPT
NEW YORK, Nov. 23, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Ra Pharmaceuticals, Inc. (NASDAQ: RARX) The.
- ACCESSWIRE
INVESTOR ALERT: Monteverde & Associates PC Continues its Investigation on the Following Transaction
NEW YORK, NY / ACCESSWIRE / November 22, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
- ACCESSWIRE
RARX, WMGI, IBKC: Monteverde & Associates PC Continues Legal Inquiry Regarding the Buyout
NEW YORK, NY / ACCESSWIRE / November 21, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
- GlobeNewswire
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of United Community, Highlands, MB Bancorp, and Ra Pharmaceuticals on behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 20, 2019 -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of United Community.
- ACCESSWIRE
SHAREHOLDER ALERT: Monteverde & Associates PC Reminds Investors of its Ongoing Inquiry Regarding the Acquisition
NEW YORK, NY / ACCESSWIRE / November 19, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
- GlobeNewswire
Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECD
NEW YORK, Nov. 16, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: William Lyon Homes (NYSE: WLH)The.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, RARX, and IPHS Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Highlands Bankshares, Inc. (HLND) in connection with the proposed acquisition of the Company by First Community Bankshares, Inc. (FCBC). Under the terms of the proposed acquisition, HLND shareholders will receive 0.273 shares of FCBC for each HLND share that they own.
- GlobeNewswire
Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – IPHS, INXN, RARX, VSI
NEW YORK, Nov. 11, 2019 -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Innophos Holdings, Inc. (NASDAQ: IPHS).
- ACCESSWIRE
SHAREHOLDER ALERT: Monteverde & Associates PC Continues Legal Inquiry Regarding the Buyout
NEW YORK, NY / ACCESSWIRE / November 7, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
- Business Wire
Ra Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
First patient dosed in the global, pivotal, Phase 3 RAISE study of zilucoplan in gMG, with top-line results expected in early 2021
- GlobeNewswire
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – VSI, RARX, SRCI, UCFC
NEW YORK, Nov. 04, 2019 -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Vitamin Shoppe, Inc. (NYSE: VSI)The.
- PR Newswire
Lifshitz & Miller LLP Announces Investigation of Achillion Pharmaceuticals, Inc., Anixter International Inc., Central European Media Enterprises Ltd., Digital Realty Trust, Inc., Fitbit, Inc., MutualFirst Financial, Inc., and Ra Pharmaceuticals Inc.
NEW YORK , Nov. 4, 2019 /PRNewswire/ -- Achillion Pharmaceuticals, Inc. (ACHN) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of ACHN to ...
- GlobeNewswire
MERGER ALERT – RARX, EMPK, and CETV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
NEW YORK, Nov. 04, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, and RARX Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Highlands Bankshares, Inc. (HLND) in connection with the proposed acquisition of the Company by First Community Bankshares, Inc. (FCBC). Under the terms of the proposed acquisition, HLND shareholders will receive 0.273 shares of FCBC for each HLND share that they own.
- GlobeNewswire
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies Is Fair to Shareholders – RARX, ACHN, IPHS, CISN
NEW YORK, Nov. 01, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Ra Pharmaceuticals, Inc. (NASDAQ: RARX)The.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Highlands Bankshares, Inc. (HLND) in connection with the proposed acquisition of the Company by First Community Bankshares, Inc. (FCBC). Under the terms of the proposed acquisition, HLND shareholders will receive 0.273 shares of FCBC for each HLND share that they own.
- Insider Monkey
Is Ra Pharmaceuticals, Inc. (RARX) Going To Burn These Hedge Funds ?
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won't accept your savings unless you commit at least $5 million) by pinpointing […]
- GlobeNewswire
MERGER ALERT – ACHN, RARX, and IPHS: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies
NEW YORK, Oct. 28, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on.
- Barrons.com
Stock Holdings in Callon Petroleum, Ra Pharmaceuticals, and More
Sizing up the ForeScout Technologies’ holdings of Jericho Capital Asset Management and Corvex Management
- GlobeNewswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
WILMINGTON, Del., Oct. 24, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Innophos Holdings, Inc. (NASDAQ GS: IPHS) regarding possible breaches of.
